CD200 and its receptors as targets for immunoregulation.
about
CD200 receptor controls sex-specific TLR7 responses to viral infectionBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemCharacterization of CD200 Ectodomain SheddingEvaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: association with disease activityInput of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.Recent advances in understanding the mechanisms of osteoclast precursor fusion.CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's diseaseGlobal expression profiling of peripheral Qa-1-restricted CD8αα+TCRαβ+ regulatory T cells reveals innate-like features: implications for immune-regulatory repertoireCD200: association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma.Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells.1α,25-dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells.Aberrant CD200/CD200R1 expression contributes to painful synovium hyperplasia in a patient with primary hypertrophic osteoarthropathy.Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice.Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200.Stress disinhibits microglia via down-regulation of CD200R: A mechanism of neuroinflammatory priming.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Putative Inflammatory Sensitive Mechanisms Underlying Risk or Resilience to Social Stress
P2860
Q24706510-1712052F-637B-4B27-A115-CCCF5F06BD9FQ26865295-D0A46F36-769C-4202-8D7B-4EC7389D8538Q28551557-78E19BA9-96E5-4465-B85C-B06C9EDB3770Q33856901-08D58735-4160-4D2E-A807-FB8372A69312Q34022979-73FCB287-240F-407B-A705-6583C8295A7CQ34033604-20F1B9B1-FC8E-43A7-8299-83C97A577F39Q34976095-21F6EF41-C0D2-4D66-B48D-1F20EBF2D855Q35175502-F91A5824-95BA-4D20-A771-B9EDE3CF319BQ35580088-0846A5F8-C2F3-46A0-B5C9-0A86334E78CDQ35680851-4CF63180-BF0A-46AA-9933-992DDE220A1CQ36019782-0EC6073F-A4EF-43B1-9DF3-7EC970D9AFAAQ36313301-2CB1163D-054F-4718-BC0B-15B35243EE69Q36316790-F52F75E6-0C77-4B09-A378-10026933EB2CQ37196363-FDAB4B78-CB88-4DCA-8981-DF08F505DD92Q37274157-1DC8EADC-3D04-49C8-B587-0D3FC330B419Q37326645-9CC683F5-51E9-4903-8B7D-8D7191DEF8E3Q37678076-E405F480-8B13-4AD5-BE59-4969EB9A5750Q39532047-3BDF9CD0-8A9F-4325-8C88-D6F799D5A906Q46971015-7F8202FC-CB58-4F37-A9D0-A17C4673FB6EQ47986361-9EF8293A-0A5F-4FB5-BBF1-BD9D46798083Q55354182-9B1982F3-B95D-4B64-8C9B-8033434E8B87Q58707532-6C6A2944-44CA-44DF-9068-705CC5E6B3EE
P2860
CD200 and its receptors as targets for immunoregulation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CD200 and its receptors as targets for immunoregulation.
@ast
CD200 and its receptors as targets for immunoregulation.
@en
type
label
CD200 and its receptors as targets for immunoregulation.
@ast
CD200 and its receptors as targets for immunoregulation.
@en
prefLabel
CD200 and its receptors as targets for immunoregulation.
@ast
CD200 and its receptors as targets for immunoregulation.
@en
P1476
CD200 and its receptors as targets for immunoregulation.
@en
P2093
Reginald M Gorczynski
P304
P577
2005-05-01T00:00:00Z